Journals / Bağcılar Tıp Bülteni / 2022 / Cilt: 7 - Sayı: 2

Could Asymmetric Dimethylarginine Have a Role in COVID-19 Cases?

Asimetrik Dimetilarjininin COVID-19’daki Rolü

Pages
102–109
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

ADMA had an inverse correlation with RDW (r=-0.391, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Coronavirus disease-2019 (COVID-19) is a disease with respiratory involvement and the virus-induced endothelial dysfunction is pronounced in the clinical course.
📊
Key Findings & Data:In COVID-19 patients, to analyze the laboratory findings and the associations may help to better understand the pathophysiology of this disease.
💡
Conclusion & Impact:ADMA had an inverse correlation with RDW (r=-0.391, p
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Coronavirus disease-2019 (COVID-19) is a disease with respiratory involvement and the virus-induced endothelial dysfunction is pronounced in the clinical course. In COVID-19 patients, to analyze the laboratory findings and the associations may help to better understand the pathophysiology of this disease. Method: We analyzed the laboratory markers including white blood cell, platelet, mean platelet volume, red cell distribution width (RDW), lactate dehydrogenase, procalcitonin, arterial blood gas values and asymmetric dimethylarginine (ADMA) levels of 83 hospitalized COVID-19 patients with pneumonia. Thirty healthy individuals were enrolled as a control group and their laboratory findings were compared. Results: No significant difference of ADMA levels (median value 225.6 μg/L vs 225.6 μg/L) was noted between COVID-19 patients and the control group (p=0.771). ADMA had an inverse correlation with RDW (r=-0.391, p

Özet

Amaç: Koronavirüs hastalığı-2019 (COVID-19) solunum tutulumu olan bir hastalıktır ve virüs kaynaklı endotelyal disfonksiyon klinik seyirde belirgindir. COVID-19 hastalarında laboratuvar bulgularının ve birlikteliklerin analiz edilmesi bu hastalığın patofizyolojisinin daha iyi anlaşılmasına yardımcı olabilir. Yöntem: Hastaneye yatırılan 83 pnömonili COVID-19 hastasının beyaz kan hücresi, trombosit, ortalama trombosit hacmi, kırmızı hücre dağıtım genişliği (RDW), laktat dehidrogenaz, prokalsitonin, arter kan gazı değerleri ve asimetrik dimetilarginin (ADMA) düzeylerini içeren laboratuvar belirteçleri incelendi. Kontrol grubu olarak 30 sağlıklı kişi alındı ve laboratuvar bulguları karşılaştırıldı. Bulgular: COVID-19 hastaları ve kontrol grubu arasında ADMA seviyelerinde (ortanca değer 225,6 μg/L’ye karşı 225,6 μg/L’ye karşı) anlamlı bir fark görülmedi (p=0,771). ADMA, RDW ile ters bir korelasyona sahipti (r=-0,391, p

🔖

Cite This Article

ÖZKARAFAKILI, M. A., BARDAKÇI, M. İ., YALÇINKAYA, Z. M., AKILLI, I. K. (2022). Could Asymmetric Dimethylarginine Have a Role in COVID-19 Cases?. Bağcılar Tıp Bülteni, Cilt: 7 - Sayı: 2, 102–109. https://ajindex.com/articles/458869

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Clinical Management of COVID-19. Available from: https://www. who.int/publications/i/item/clinical-management-of-covid-19 2. Razeghian-Jahromi I, Zibaeenezhad MJ, Lu Z, Zahra E, Mahboobeh R, Lionetti V. Angiotensin-converting enzyme 2: a double-edged sword in COVID-19 patients with an increased risk of heart failure. Heart Fail Rev 2021
  2. 26(2):371-380. 3. Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and edotheliitis in COVID-19. Lancet 2020
  3. 395(10234):1417-1418. 4. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020
  4. m1091. 5. Rabelo LA, Todiras M, Nunes-Souza V, Qadri F, Szijártó IA, Gollasch M, et al. Genetic Deletion of ACE2 Induces Vascular Dysfunction in C57BL/6 Mice: Role of Nitric Oxide Imbalance and Oxidative Stress. PLoS One 2016
  5. 11(4):e0150255. 6. Levine AB, Punihaole D, Levine TB. Characterization of the role of nitric oxide and its clinical applications. Cardiology 2012
  6. 122(1):55- 68. 7. Xu W, Zheng S, Dweik RA, Erzurum SC. Role of epithelial nitric oxide in airway viral infection. Free Radic Biol Med 2006
  7. 41(1):19- 28. 8. Akerström S, Gunalan V, Keng CT, Tan YJ, Mirazimi A. Dual effect of nitric oxide on SARS-CoV replication: Viral RNA production and palmitoylation of the S protein are affected, Virology 2009
  8. 395(1):1-9. 9. Chen L, Liu P, Gao H, Sun B, Chao D, Wang F, et al. Inhalation of Nitric Oxide in the Treatment of Severe Acute Respiratory Syndrome: A Rescue Trial in Beijing, Clin Infect Dis 2004
  9. 39(10):1531-1535. 10. Abou-Arab O, Huette P, Debouvries F, Dupont H, Jounieaux V, Mahjoub Y. Inhaled nitric oxide for critically ill Covid-19 patients: a prospective study. Crit Care 2020
  10. 24(1):645. 11. Palmer RM, Rees DD, Ashton DS, Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation, Biochem and Biophys Res Commun 1988
  11. 153(3):1251-1256. 12. Böger RH. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor, Cardiovasc Res 2003
  12. 59(4):825- 833. 13. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992
  13. 339(8793):572-575. 14. Krempl TK, Maas R, Sydow K, Meinertz T, Böger RH, Kähler J. Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent